Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Blocking mTORC1 reduces skin tumor growth in mice.

Baricitinib was effective in treating both early and late onset alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

The lotion safely and effectively reduces unwanted hair growth.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tirzepatide may improve hair loss by reducing insulin resistance.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.